Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TN › Bristol › NPI 1124058615
Hospital

Wellmont Health System

Wellmont Health System was paid $27.35M by Medicaid between Jan 2018 and Dec 2024, across 242 billing codes. Its largest line is 99284, emergency room visit (serious) — 31% of everything it billed.

33Billing provider infoWELLMONT HEALTH SYSTEM
BRISTOL, TN 37620
33aNPI1124058615assigned 07/03/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$27.35M
24GClaims593,002
24DCodes billed242
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Tennessee

Rank by total paid#9 of 71
Median peer was paid$6.96M
This provider vs. median3.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official HILTON, SHANE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201872,913$2.86M
201994,908$3.34M
202078,573$3.44M
202190,579$4.08M
202288,415$4.28M
202395,410$4.96M
2024incomplete72,204$4.38M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 31% 42,726 37,393 $8.49M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 14% 19,791 16,974 $3.91M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 10% 19,684 17,490 $2.76M
96361 Intravenous infusion, hydration; each additional hour 5.9% 6,477 5,151 $1.62M
74177 Computed tomography, abdomen and pelvis; with contrast material 3.3% 4,682 4,224 $915K
41899 Unlisted procedure, dentoalveolar structures 3.0% 948 911 $834K
70450 Computed tomography, head or brain; without contrast material 2.7% 4,294 3,779 $728K
G0378 Hospital observation service, per hour 2.2% 5,741 3,672 $605K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.8% 4,953 4,479 $504K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.6% 10,484 3,110 $446K
74176 Computed tomography, abdomen and pelvis; without contrast material 1.3% 1,782 1,608 $361K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.3% 1,341 1,229 $359K
230 more codes
29581 1.2% 2,487 $340K
97530 Therapeutic activities, direct patient contact, each 15 minutes 1.1% 6,238 $296K
0202U Oncology (prostate), multianalyte, gene expression profiling 1.1% 2,874 $288K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 1.0% 484 $282K
97602 1.0% 1,538 $275K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,813 $231K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 2,889 $228K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 4,161 $221K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 2,071 $206K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 3,487 $205K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 4,474 $195K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 1,236 $192K
71275 Computed tomographic angiography, chest, with contrast material <1% 544 $140K
59025 Fetal non-stress test <1% 775 $136K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,451 $131K
80053 Comprehensive metabolic panel <1% 36,823 $127K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 16,974 $127K
99213 Doctor's office visit, returning patient (routine) <1% 1,133 $100K
71046 Radiologic examination, chest; 2 views <1% 11,273 $100K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 538 $99K
97162 <1% 1,468 $97K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 392 $96K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 45,926 $78K
C8929 Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography <1% 359 $77K
93017 <1% 774 $75K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 261 $74K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,778 $74K
78306 <1% 322 $73K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 1,018 $64K
72141 <1% 345 $60K
80048 Basic metabolic panel (calcium, ionized) <1% 12,272 $52K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 2,217 $51K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 563 $50K
97116 <1% 2,153 $44K
93971 <1% 540 $41K
72100 <1% 2,143 $40K
78815 Positron emission tomography (PET) for limited area imaging <1% 78 $39K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 14,812 $37K
49083 <1% 60 $36K
99214 Doctor's office visit, returning patient (more involved) <1% 242 $33K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 241 $33K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 63 $25K
36415 Collection of venous blood by venipuncture <1% 19,109 $24K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 2,548 $23K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 134 $23K
83880 <1% 3,393 $22K
71045 Radiologic examination, chest; single view <1% 5,162 $21K
72125 Computed tomography, cervical spine; without contrast material <1% 960 $20K
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) <1% 449 $19K
84484 <1% 11,595 $17K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 793 $16K
70551 Magnetic resonance imaging, brain; without contrast material <1% 71 $16K
73562 <1% 1,483 $15K
95813 <1% 31 $14K
74018 <1% 1,473 $13K
95816 <1% 66 $13K
72131 <1% 272 $12K
99215 Doctor's office visit, returning patient (complex) <1% 54 $12K
87040 <1% 1,671 $12K
76536 <1% 120 $12K
81025 <1% 8,018 $11K
76642 <1% 100 $11K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 338 $11K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 8,665 $10K
J7030 Infusion, normal saline solution , 1000 cc <1% 8,987 $10K
85027 <1% 6,036 $9K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 12 $9K
84443 Thyroid stimulating hormone (TSH) <1% 2,525 $9K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 52 $8K
29445 <1% 49 $8K
73630 <1% 972 $8K
77063 Screening digital breast tomosynthesis, bilateral <1% 260 $8K
93923 <1% 83 $8K
71250 <1% 102 $8K
81001 <1% 17,007 $7K
70496 <1% 28 $7K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 7,684 $7K
J7120 Ringers lactate infusion, up to 1000 cc <1% 5,416 $7K
73030 <1% 841 $7K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 14,350 $7K
90715 <1% 335 $6K
72040 <1% 168 $6K
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 7,414 $6K
62323 <1% 32 $5K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 97 $5K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 493 $5K
76770 <1% 30 $4K
G0279 Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) <1% 267 $4K
76830 Ultrasound, transvaginal <1% 44 $4K
73130 <1% 661 $4K
73502 <1% 384 $4K
73610 <1% 740 $4K
96375 Therapeutic injection; each additional sequential IV push <1% 7,602 $4K
80061 Lipid panel <1% 947 $4K
85379 <1% 979 $4K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 6,370 $4K
83036 Hemoglobin; glycosylated (A1C) <1% 905 $4K
J7050 Infusion, normal saline solution, 250 cc <1% 1,028 $4K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 3,242 $3K
72050 <1% 133 $3K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 5,977 $3K
83690 <1% 7,954 $3K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 16 $3K
77066 Tomosynthesis, mammo <1% 58 $3K
77002 <1% 13 $3K
83735 <1% 3,147 $3K
97165 <1% 15 $3K
77065 Tomosynthesis, mammo <1% 60 $2K
72020 <1% 145 $2K
12001 <1% 13 $2K
81003 <1% 7,131 $2K
96376 <1% 3,364 $2K
J1650 Injection, enoxaparin sodium, 10 mg <1% 2,707 $2K
Q9965 Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml <1% 227 $2K
88307 <1% 130 $2K
97535 Self-care/home management training, each 15 minutes <1% 95 $2K
97166 <1% 15 $2K
87205 <1% 134 $2K
85652 <1% 1,044 $2K
86140 <1% 441 $2K
85610 <1% 2,200 $2K
93880 <1% 33 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 7,235 $2K
76801 <1% 34 $2K
J3490 Unclassified drugs <1% 4,066 $1K
83605 <1% 1,186 $1K
77336 <1% 29 $1K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 82 $1K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 71 $1K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 1,578 $1K
A9585 Injection, gadobutrol, 0.1 ml <1% 1,787 $1K
J1170 Injection, hydromorphone, up to 4 mg <1% 7,827 $1K
87086 Culture, bacterial; quantitative colony count, urine <1% 2,985 $1K
87536 <1% 14 $1K
85730 <1% 753 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 409 $1K
71271 <1% 12 $976.84
82565 <1% 494 $738.32
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 55 $729.00
87081 <1% 1,106 $681.17
G0297 Low dose ct scan (ldct) for lung cancer screening <1% 14 $680.61
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 304 $640.52
73110 <1% 149 $623.63
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 14 $591.70
J2270 Injection, morphine sulfate, up to 10 mg <1% 5,009 $590.02
86901 <1% 1,095 $589.40
80076 <1% 180 $573.73
80143 <1% 128 $545.60
70486 <1% 13 $522.08
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 930 $513.68
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,323 $503.07
99203 Doctor's office visit, new patient (routine) <1% 14 $487.95
84100 <1% 981 $480.66
70498 <1% 15 $400.42
87210 <1% 186 $341.80
85055 <1% 67 $325.71
80179 <1% 122 $324.04
82607 <1% 40 $297.59
72072 <1% 12 $296.04
87186 <1% 859 $290.16
86850 <1% 654 $267.45
84702 <1% 453 $261.78
80320 <1% 294 $246.70
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 353 $237.43
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 56 $218.28
J0690 Injection, cefazolin sodium, 500 mg <1% 4,029 $213.80
J2785 Injection, regadenoson, 0.1 mg <1% 215 $199.26
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,129 $182.15
86900 <1% 1,020 $181.81
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,491 $177.97
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 860 $167.93
82570 <1% 110 $162.74
84439 <1% 62 $160.68
87077 <1% 837 $159.92
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 437 $141.09
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 19 $137.45
84703 <1% 293 $130.04
Q9950 Injection, sulfur hexafluoride lipid microspheres, per ml <1% 484 $108.47
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 498 $107.92
87070 <1% 149 $104.05
82728 <1% 12 $77.50
94760 <1% 6,499 $66.52
J1815 Injection, insulin, per 5 units <1% 692 $66.23
88304 <1% 140 $49.68
A9270 Non-covered item or service <1% 7,376 $49.65
36600 <1% 31 $48.14
99152 <1% 151 $36.04
J0780 Injection, prochlorperazine, up to 10 mg <1% 586 $34.78
J1630 Injection, haloperidol, up to 5 mg <1% 279 $32.42
J2060 Injection, lorazepam, 2 mg <1% 284 $25.57
82140 <1% 13 $24.68
A9503 Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries <1% 388 $23.64
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 717 $23.29
84156 <1% 34 $22.43
85007 <1% 32 $20.96
87807 <1% 256 $19.63
J2550 Injection, promethazine hcl, up to 50 mg <1% 280 $18.79
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 150 $18.32
73080 <1% 17 $10.51
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 86 $6.76
83615 <1% 14 $5.05
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 20 $1.79
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 13 $1.76
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 151 $1.45
J1644 Injection, heparin sodium, per 1000 units <1% 52 $0.71
J1940 Injection, furosemide, up to 20 mg <1% 15 $0.09
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 0% 51 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 93 $0.00
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg 0% 141 $0.00
J0688 Injection, cefazolin sodium (hikma), not therapeutically equivalent to j0690, 500 mg 0% 73 $0.00
J3370 Injection, vancomycin hcl, 500 mg 0% 79 $0.00
J0735 Injection, clonidine hydrochloride, 1 mg 0% 81 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 49 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 0% 92 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 122 $0.00
C9113 Injection, pantoprazole sodium, per vial 0% 26 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 43 $0.00
76000 0% 51 $0.00
C1776 Joint device (implantable) 0% 12 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 111 $0.00
C1769 Guide wire 0% 258 $0.00
J2704 Injection, propofol, 10 mg 0% 4,184 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 491 $0.00
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 0% 53 $0.00
99153 Mod sedat endo service >5yrs 0% 26 $0.00
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml 0% 52 $0.00
94761 0% 40 $0.00
J2373 Injection, phenylephrine hydrochloride (immphentiv), 20 micrograms 0% 16 $0.00
71101 0% 28 $0.00
73090 0% 29 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHILTON, SHANE (EVP/CFO)
Same official

Other billing entities under HILTON, SHANE

Full network →
ProviderLocationPaid
Johnston Memorial Hospital, INCAbingdon, VA$35.91M
Wellmont Health SystemBig Stone Gap, VA$33.71M
Mountain States Health AllianceJohnson City, TN$31.31M
Wellmont Medical Associates INCKingsport, TN$27.84M
Takoma Regional Hospital INCGreeneville, TN$20.22M
Wellmont Health SystemKingsport, TN$17.64M
Mountain States Health AllianceKingsport, TN$15.47M
Smyth County Community HospitalMarion, VA$15.33M
Mountain States Health AllianceLebanon, VA$11.37M
Mountain States Health AlliancePennington Gap, VA$8.28M
Mountain States Health AllianceJohnson City, TN$8.14M
Mountain States Health AllianceElizabethton, TN$7.25M
Dickenson Community Hospital, INC.Clintwood, VA$6.94M
Wellmont Hawkins County Memorial Hospital INCRogersville, TN$5.11M
East Tennessee Healthcare Holdings INCGray, TN$3.30M
Mountain States Health AllianceMountain City, TN$3.03M
Wellmont Health SystemSneedville, TN$1.90M
Mountain States Health AllianceErwin, TN$1.48M
Wilson Pharmacy INCJohnson City, TN$1.26M
Mountain States Health AllianceNorton, VA$376K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.